The Regents of the University of Colorado, a body corporate;National Jewish Health
发明人:
申请号：
EP16737819.9
公开号：
EP3247384A4
申请日:
2016.01.13
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
Methods for inhibiting an autoimmune disease by administering to a subject a therapeutically effective amount of a composition that induces conversion of naive T cells into Foxp3+ regulatory T cells to induce immunosuppression in the subject. Methods for detecting in a subject an autoimmune disease or a predisposition to a autoimmune disease, and methods for assessing the efficacy of a therapy for an autoimmune disease, particularly type 1 diabetes.
